Table 3. Persistent COVID-19 symptoms six months after infection. Fortaleza (CE), 2022.
| Persistent symptoms after the COVID-19 infection period | |
|---|---|
| Cardiovascular | 60 (44.4) |
| Palpitation | 30 (22.2) |
| Chest pain | 2 (1.5) |
| SAH | 5 (3.7) |
| Palpitation and SAH | 23 (17.0) |
| Respiratory | 108 (80) |
| Minor fatigue | 54 (40) |
| Fatigue on medium exertion | 26 (19.3) |
| Tiredness upon heavy exertion | 23 (17) |
| Persistent cough | 3 (2.2) |
| Dermatological | 78 (57.8) |
| Hair loss | 44 (32.6) |
| Dermatitis | 15 (11.1) |
| Hair loss and dermatitis | 18 (13.3) |
| Musculoskeletal | 72 (53.3) |
| Myoarticular pain | 31 (23) |
| Muscle fatigue/weakness | 32 (23.7) |
| Pain and fatigue and muscle weakness | 8 (5.9) |
| Neurological | 101 (74.8) |
| Memory loss | 51 (37.8) |
| Concentration deficit | 7 (5.2) |
| Memory loss and concentration deficit | 40 (29.6) |
| Paresthesia of limbs | 3 (2.2) |
| Psychological | 102 (75.6) |
| Anxiety | 65 (48.1) |
| Depression | 9 (6.7) |
| Anxiety and depression | 22 (16.3) |
| Irritability or stress | 7 (5.2) |
| Activity and participation after COVID-19 infection | |
| Required help with self-care activities after COVID-19 | 27 (20) |
| Stopped performing activities (work, sports, and/or leisure) after COVID-19 | 47 (34.8) |
SAH: Systemic Arterial Hypertension (Brazilian Guidelines on Systemic Arterial Hypertension).